Cancer outcomes in people with blood disorders like thalassemia or sickle cell
Part of Blood & lymphatic, Cancer clinical trials.
This study looks at how cancers occur and what they look like in people with certain inherited blood disorders, such as beta-thalassemia, hemoglobin H disease, and sickle cell disease. It may help doctors better understand cancer patterns in these conditions so care can be improved.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have (now or before) an inherited blood disorder: beta-thalassemia, hemoglobin H disease, sickle cell anemia, or microdrepanocytosis
- You have had cancer now or in the past (a malignant tumor)
- You can share your medical records from before your cancer started
- Your records include key clinical details and test results (clinical and instrumental data) from that time
- You do not have another blood disease besides the hemoglobin disorders listed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at bone marrow cells that would otherwise be discarded during some orthopedic surgeries. It may help researchers learn more about specific blood disorders (certain types of thalassemia and sickle cell–related conditions).
This observational study looks at people with thalassemia, sickle cell disease, or other inherited anemia who have COVID-19. It aims to learn how COVID affects these conditions and may help improve care planning.
This study looks at how your genes can affect inherited blood conditions like sickle cell disease and thalassemia. It may help researchers understand why symptoms differ from person to person, which could guide better future treatments.
This study follows adults who are being checked for a possible blood cancer, or who were recently diagnosed with a blood cancer within the last 6 months. It may help doctors understand the condition better and improve how early workups and care are organized.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This trial studies how different blood cancers and early (pre-cancer) blood conditions work, using tumor/blood tissue samples. It may help researchers learn more about disease biology for future treatments, with little to no extra risk if samples come from routine care.
Hear when a new Malignacy, Hemoglobinopathie trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.